To analyze disease relapses within a well-characterized neurosarcoidosis cohort, with particular attention to length of illness, other organ system involvement, treatment strategy and duration, lesion location, and outcomes in patients with neurosarcoidosis within the University of Utah Healthcare System

Refractory epilepsy is not uncommon in pediatric patients; consideration of whether seizures are acutely symptomatic of a primary disease process is critical. In this case, a healthy 7-year-old child presented with intractable focal seizures in the setting of a mild viral prodrome and headache. This case highlights a comprehensive work up of new-onset, refractory epilepsy in a patient with features of encephalitis, and it describes a diagnostic quandary that ultimately led to a rare unifying diagnosis.

Determine the frequency of depression and anxiety in a neuromyelitis optica spectrum disease (NMOSD) population pre and post NMOSD diagnosis.

To characterize the social determinants of health (SDOH) impacting anti-NMDAR encephalitis patients.

To evaluate safety and utility of electroconvulsive therapy (ECT) in patients with NMDARE through a systematic literature review and a retrospective, multi-center cohort.

Summarize the demographic/clinical characteristics and efficacy outcomes of individuals with pediatric-onset multiple sclerosis (POMS) who were treated with Avonex or Plegridy

Determine difference in frequency of depression and anxiety diagnoses for patients diagnosed with neuromyelitis optica spectrum disease (NMOSD) compared to patients diagnosed with multiple sclerosis (MS).

Describe the clinical course, diagnostic approach and outcomes following thymectomy in four non-myasthenic patients with synaptic antibody-mediated autoimmune neurologic disease.

To assess the demographic, clinical, and outcome data in patients with isolated optic neuritis (ON) across a large pediatric and adult cohort.

Determine most common symptom diagnoses of neuromyelitis optica spectrum disease (NMOSD) pre- and post-NMOSD diagnosis and how the symptoms are followed.

Describe population healthcare utilization trends and identify potential barriers and social determinants of health in a national cohort of young patients with NMOSD.